Cellular Therapy Account Director (CTAD) - Northeast (NY, MA, CT, NH, ME, RI, VT)

Votre mission

=================

Pierre Fabre is a large private French multinational pharmaceutical organization that is building a new US division with a focus on rare diseases and oncology products. We are looking for creative, highly motivated individuals to help to drive the successful launch of tabelecleucel (Tab-cel), as part of the initial Cellular Therapy Director (CTAD) team, you will be focused on delivering results with innovative solutions for complex patients suffering from a devastating rare disease, Epstein-Barr Virus Positive Post Transplant Lymphoproliferative Disease (EBV+ PTLD). Patients with a history of bone marrow or solid organ transplant can suffer from this rare, often deadly lymphoma. This is an opportunity for “builders” those who are looking to contribute to the creation of a new US organization, with a potentially transformative therapy, and we are looking for candidates that have a growth mindset and thrive in a start-up environment that will be scaling up the Pierre Fabre presence in the US pharmaceuticals market. We value individuals who exhibit behaviors such as team collaboration, humility, innovative thinking, and a patient-centric approach to the business.

In the preapproval phase, the CTAD will be responsible for leading disease awareness efforts, developing relationships with both the clinical and non-clinical experts to understand unmet need and patient journey, as well as leading the onboarding process for launching an allogeneic cell therapy. Post-approval, the CTADs will be responsible for appropriately driving demand and working cross functionally to support utilization and treatment experience of Tab-cel within institutions in their assigned territory.

ESSENTIAL FUNCTIONS

• Operate in compliance with all laws, regulations and policies that govern the conduct of Pierre Fabre activities
• Effectively navigate complex account environments by identifying and understanding the needs and challenges